Searched for
US DRUG GIANT
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Yum Brands in exclusive talks to sell Pizza Hut to LongRange Capital, source saysYum Brands is reportedly in exclusive talks with private-equity firm LongRange Capital for a potential sale of its Pizza Hut chain. This mo...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...
- Iran's economy has been battered. Its leaders still think Trump will blink firstIran's economy faces severe disruption from U.S. and Israeli strikes. Factories are shut, leading to mass job losses and soaring prices for...
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Pharmaceutical logistics in demand as war rattles supply chainsMedicines are vital but useless if lost or spoiled. Pharmaceutical logistics ensures their safe delivery. DHL's Florstadt campus near Frank...
- MSF drags govt to Delhi HC over Pfizer's pneumonia vaccine patentThe Indian patent office granted Pfizer a patent for its vaccine PCV13 (13-valent pneumococcal conjugate vaccine), sold here under the bran...
- MSF and Pfizer battle over patent application for life-saving pneumonia vaccineMSF filed declarations at the Delhi patent office to point out that Pfizer's 13-valent pneumococcal conjugate vaccine (PCV13) was obvious a...
- Pfizer to reportedly sign a deal to buy Allergan for $150 billion; to be drug industry's biggest dealUS drug giant Pfizer is reportedly moving closer to sign a deal to buy Botox maker Allergan for $150 billion, or about Rs 9,88,000 crore.
- Delhi High Court seeks Glenmark's response on US drug giant MSD's appealJustice S Ravindra Bhat and SK Mishra issued a notice to Glenmark and sought its reply by May 22 on the US firm's plea challenging the sing...
- TEVA TO buy local unit for Rs 400 crThe world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...
- Generic vs generic: Drug cos battle to protect turfGeneric drug makers, which have typically waged legal battles against innovator pharma giants, are now suing each other to protect their ma...
- Wal-Mart may source Indian genericsHere’s the big break Indian pharma majors have been looking for in their global game. Raj Jain, Wal-Mart’s chief executive designate for In...
Load More
